NASH may soon become most common liver transplant etiology
Results of a recent study showed that nonalcoholic steatohepatitis was the most rapidly growing cause of hepatocellular carcinoma among U.S. patients listed for liver transplantation.
“The prevalence of HCC seems to be growing at a significantly higher pace for the waitlisted patients with NASH as compared to the other common causes of chronic liver disease,” Zobair M. Younossi, MD, from the Inova Fairfax Hospital in Virginia, and colleagues wrote. “It is plausible that patients with NASH may actually present late in the course of their disease with more advanced liver disease and higher stage HCC, both of which can potentially affect their status on the transplant list and their post-LT outcomes.”
Click here for the full article.